MPV17L and diabetes mellitus: In the present study, deficiency of M-LP/Mpv17L was found to alleviate certain pathological aspects of STZ-induced diabetes such as (1) increased blood glucose levels, (2) down-regulation of β-cell-specific genes, and (3) increased histological changes and damage.